Skip to main content
Top
Published in: Journal of Nuclear Cardiology 1/2012

01-02-2012 | Original Article

Nomograms for estimating coronary artery disease prognosis with gated stress myocardial perfusion SPECT

Authors: Leslee J. Shaw, PhD, James K. Min, MD, Rory Hachamovitch, MD, MS, Robert C. Hendel, MD, Salvador Borges-Neto, MD, Daniel S. Berman, MD

Published in: Journal of Nuclear Cardiology | Issue 1/2012

Login to get access

Abstract

Background

Nomograms can be useful tools for estimating coronary artery disease (CAD) risk. We sought to devise risk-based nomograms for stress myocardial perfusion SPECT to include measures of % ischemic myocardium and left ventricular function.

Methods

A total of 4,575 patients were consecutively and prospectively enrolled in the Myoview Prognosis Registry. Multivariable Cox proportional hazards model were employed to estimate CAD death or MI. Nomograms were devised from the results of the Cox models.

Results

CAD death or MI rates worsened in a gradient manner by the % ischemic myocardium. Higher risk patients were those with a rest and/or post-stress LVEF ≤ 45%. A nomogram was developed to estimate 2-year CAD death or MI-free survival for exercising and pharmacologic stress patients by their post-stress LVEF and % ischemic myocardium MPS results. Patients undergoing pharmacologic stress with a rest and/or post-stress LVEF ≤ 45% with high risk ischemic findings had the lowest CAD death or MI event-free survival. For exercising patients with a preserved resting LVEF > 45%, 2-year CAD death or MI event-free survival ranged from 99.4% to 89% for 0% to ≥20% ischemic myocardium. Those at highest risk included patients undergoing pharmacologic stress with depressed LVEF. For pharmacologic stress patients with a resting LVEF ≤45%, 2-year CAD death or MI event-free survival ranged from 89% to 48% for 0% to ≥20% ischemic myocardium. For pharmacologic stress patients with a post-stress LVEF ≤ 45%, 2-year CAD death or MI event-free survival ranged from 88% to 46% for 0% to ≥20% ischemic myocardium. A validation cohort revealed moderate-strong correlation between observed and predicted survival (r = 0.71). Average discordance between observed and predicted survival was ≤2% but was greater for higher risk patients with lower predicted survival estimates.

Conclusions

Risk-based nomograms estimating important CAD outcomes may serve as a clinically useful tool to target therapeutic intervention for high risk patient subsets.
Literature
1.
go back to reference Shaw LJ, Marwick TH, Zoghbi WA, Hundley WG, Kramer CM, Achenbach S, et al. Why all the focus on cardiac imaging? JACC Cardiovasc Imaging 2010;3:789-94.PubMedCrossRef Shaw LJ, Marwick TH, Zoghbi WA, Hundley WG, Kramer CM, Achenbach S, et al. Why all the focus on cardiac imaging? JACC Cardiovasc Imaging 2010;3:789-94.PubMedCrossRef
2.
go back to reference Shaw LJ, Min JK, Hachamovitch R, Peterson ED, Hendel RC, Woodard PK, et al. Cardiovascular imaging research at the crossroads. JACC Cardiovasc Imaging 2010;3:316-24.PubMedCrossRef Shaw LJ, Min JK, Hachamovitch R, Peterson ED, Hendel RC, Woodard PK, et al. Cardiovascular imaging research at the crossroads. JACC Cardiovasc Imaging 2010;3:316-24.PubMedCrossRef
3.
go back to reference Hachamovitch R, Hayes SW, Friedman JD, Cohen I, Berman DS. A prognostic score for prediction of cardiac mortality risk after adenosine stress myocardial perfusion scintigraphy. J Am Coll Cardiol 2005;45:722-9.PubMedCrossRef Hachamovitch R, Hayes SW, Friedman JD, Cohen I, Berman DS. A prognostic score for prediction of cardiac mortality risk after adenosine stress myocardial perfusion scintigraphy. J Am Coll Cardiol 2005;45:722-9.PubMedCrossRef
4.
go back to reference Shaw LJ, Wilson PW, Hachamovitch R, Hendel RC, Borges-Neto S, Berman DS. Improved near-term coronary artery disease risk classification with gated stress myocardial perfusion SPECT. JACC Cardiovasc Imaging 2010;3:1139-48.PubMedCrossRef Shaw LJ, Wilson PW, Hachamovitch R, Hendel RC, Borges-Neto S, Berman DS. Improved near-term coronary artery disease risk classification with gated stress myocardial perfusion SPECT. JACC Cardiovasc Imaging 2010;3:1139-48.PubMedCrossRef
5.
go back to reference Shaw LJ, Hendel RC, Cerquiera M, Mieres JH, Alazraki N, Krawczynska E, et al. Ethnic differences in the prognostic value of stress technetium-99m tetrofosmin gated single-photon emission computed tomography myocardial perfusion imaging. J Am Coll Cardiol 2005;45:1494-504.PubMedCrossRef Shaw LJ, Hendel RC, Cerquiera M, Mieres JH, Alazraki N, Krawczynska E, et al. Ethnic differences in the prognostic value of stress technetium-99m tetrofosmin gated single-photon emission computed tomography myocardial perfusion imaging. J Am Coll Cardiol 2005;45:1494-504.PubMedCrossRef
6.
go back to reference Shaw LJ, Hendel R, Borges-Neto S, Lauer MS, Alazraki N, Burnette J, et al. Prognostic value of normal exercise and adenosine (99m)tc-tetrofosmin SPECT imaging: Results from the multicenter registry of 4, 728 patients. J Nucl Med 2003;44:134-9.PubMed Shaw LJ, Hendel R, Borges-Neto S, Lauer MS, Alazraki N, Burnette J, et al. Prognostic value of normal exercise and adenosine (99m)tc-tetrofosmin SPECT imaging: Results from the multicenter registry of 4, 728 patients. J Nucl Med 2003;44:134-9.PubMed
7.
go back to reference Shaw LJ, Hendel RC, Heller GV, Borges-Neto S, Cerqueira M, Berman DS. Prognostic estimation of coronary artery disease risk with resting perfusion abnormalities and stress ischemia on myocardial perfusion SPECT. J Nucl Cardiol 2008;15:762-73.PubMed Shaw LJ, Hendel RC, Heller GV, Borges-Neto S, Cerqueira M, Berman DS. Prognostic estimation of coronary artery disease risk with resting perfusion abnormalities and stress ischemia on myocardial perfusion SPECT. J Nucl Cardiol 2008;15:762-73.PubMed
8.
go back to reference Gibbons RJ, Balady GJ, Bricker JT, Chaitman BR, Fletcher GF, Froelicher VF, et al. ACC/AHA 2002 guideline update for exercise testing: Summary article. A report of the American College of Cardiology/American Heart Association Task Force On Practice Guidelines (committee to update the 1997 exercise testing guidelines). J Am Coll Cardiol 2002;40:1531-40.PubMedCrossRef Gibbons RJ, Balady GJ, Bricker JT, Chaitman BR, Fletcher GF, Froelicher VF, et al. ACC/AHA 2002 guideline update for exercise testing: Summary article. A report of the American College of Cardiology/American Heart Association Task Force On Practice Guidelines (committee to update the 1997 exercise testing guidelines). J Am Coll Cardiol 2002;40:1531-40.PubMedCrossRef
9.
go back to reference Hansen CL, Goldstein RA, Akinboboye OO, Berman DS, Botvinick EH, Churchwell KB, et al. Myocardial perfusion and function: Single photon emission computed tomography. J Nucl Cardiol 2007;14:e39-60.PubMedCrossRef Hansen CL, Goldstein RA, Akinboboye OO, Berman DS, Botvinick EH, Churchwell KB, et al. Myocardial perfusion and function: Single photon emission computed tomography. J Nucl Cardiol 2007;14:e39-60.PubMedCrossRef
10.
go back to reference Hachamovitch R, Rozanski A, Shaw LJ, Stone GW, Thomson LE, Friedman JD, et al. Impact of ischaemia and scar on the therapeutic benefit derived from myocardial revascularization vs. Medical therapy among patients undergoing stress-rest myocardial perfusion scintigraphy. Eur Heart J 2011;32:1012-24.PubMedCrossRef Hachamovitch R, Rozanski A, Shaw LJ, Stone GW, Thomson LE, Friedman JD, et al. Impact of ischaemia and scar on the therapeutic benefit derived from myocardial revascularization vs. Medical therapy among patients undergoing stress-rest myocardial perfusion scintigraphy. Eur Heart J 2011;32:1012-24.PubMedCrossRef
11.
go back to reference Hachamovitch R, Rozanski A, Hayes SW, Thomson LE, Germano G, Friedman JD, et al. Predicting therapeutic benefit from myocardial revascularization procedures: Are measurements of both resting left ventricular ejection fraction and stress-induced myocardial ischemia necessary? J Nucl Cardiol 2006;13:768-78.PubMedCrossRef Hachamovitch R, Rozanski A, Hayes SW, Thomson LE, Germano G, Friedman JD, et al. Predicting therapeutic benefit from myocardial revascularization procedures: Are measurements of both resting left ventricular ejection fraction and stress-induced myocardial ischemia necessary? J Nucl Cardiol 2006;13:768-78.PubMedCrossRef
12.
go back to reference Mark DB, Shaw L, Harrell FE Jr, Hlatky MA, Lee KL, Bengtson JR, McCants CB, et al. Prognostic value of a treadmill exercise score in outpatients with suspected coronary artery disease. N Engl J Med 1991;325:849-53.PubMedCrossRef Mark DB, Shaw L, Harrell FE Jr, Hlatky MA, Lee KL, Bengtson JR, McCants CB, et al. Prognostic value of a treadmill exercise score in outpatients with suspected coronary artery disease. N Engl J Med 1991;325:849-53.PubMedCrossRef
13.
go back to reference Garg S, Sarno G, Garcia-Garcia HM, Girasis C, Wykrzykowska J, Dawkins KD, et al. A new tool for the risk stratification of patients with complex coronary artery disease: The clinical syntax score. Circ Cardiovasc Interv 2010;3:317-26.PubMedCrossRef Garg S, Sarno G, Garcia-Garcia HM, Girasis C, Wykrzykowska J, Dawkins KD, et al. A new tool for the risk stratification of patients with complex coronary artery disease: The clinical syntax score. Circ Cardiovasc Interv 2010;3:317-26.PubMedCrossRef
14.
go back to reference Wykrzykowska JJ, Garg S, Girasis C, de Vries T, Morel MA, van Es GA, et al. Value of the syntax score for risk assessment in the all-comers population of the randomized multicenter leaders (limus eluted from a durable versus erodable stent coating) trial. J Am Coll Cardiol 2010;56:272-7.PubMedCrossRef Wykrzykowska JJ, Garg S, Girasis C, de Vries T, Morel MA, van Es GA, et al. Value of the syntax score for risk assessment in the all-comers population of the randomized multicenter leaders (limus eluted from a durable versus erodable stent coating) trial. J Am Coll Cardiol 2010;56:272-7.PubMedCrossRef
15.
go back to reference Chakravarty T, Buch MH, Naik H, White AJ, Doctor N, Schapira J, et al. Predictive accuracy of syntax score for predicting long-term outcomes of unprotected left main coronary artery revascularization. Am J Cardiol 2011;107:360-6.PubMedCrossRef Chakravarty T, Buch MH, Naik H, White AJ, Doctor N, Schapira J, et al. Predictive accuracy of syntax score for predicting long-term outcomes of unprotected left main coronary artery revascularization. Am J Cardiol 2011;107:360-6.PubMedCrossRef
16.
go back to reference Antman EM, Cohen M, Bernink PJ, McCabe CH, Horacek T, Papuchis G, et al. The TIMI risk score for unstable angina/non-ST elevation mi: A method for prognostication and therapeutic decision making. JAMA 2000;284:835-42.PubMedCrossRef Antman EM, Cohen M, Bernink PJ, McCabe CH, Horacek T, Papuchis G, et al. The TIMI risk score for unstable angina/non-ST elevation mi: A method for prognostication and therapeutic decision making. JAMA 2000;284:835-42.PubMedCrossRef
17.
go back to reference Sanchis J, Bodi V, Nunez J, Bertomeu-Gonzalez V, Gomez C, Bosch MJ, et al. New risk score for patients with acute chest pain, non-ST-segment deviation, and normal troponin concentrations: A comparison with the TIMI risk score. J Am Coll Cardiol 2005;46:443-9.PubMedCrossRef Sanchis J, Bodi V, Nunez J, Bertomeu-Gonzalez V, Gomez C, Bosch MJ, et al. New risk score for patients with acute chest pain, non-ST-segment deviation, and normal troponin concentrations: A comparison with the TIMI risk score. J Am Coll Cardiol 2005;46:443-9.PubMedCrossRef
18.
go back to reference Morrow DA, Antman EM, Parsons L, de Lemos JA, Cannon CP, Giugliano RP, et al. Application of the TIMI risk score for ST-elevation mi in the national registry of myocardial infarction 3. JAMA 2001;286:1356-9.PubMedCrossRef Morrow DA, Antman EM, Parsons L, de Lemos JA, Cannon CP, Giugliano RP, et al. Application of the TIMI risk score for ST-elevation mi in the national registry of myocardial infarction 3. JAMA 2001;286:1356-9.PubMedCrossRef
19.
go back to reference Shaw LJ, Iskandrian AE. Prognostic value of gated myocardial perfusion SPECT. J Nucl Cardiol 2004;11:171-85.PubMedCrossRef Shaw LJ, Iskandrian AE. Prognostic value of gated myocardial perfusion SPECT. J Nucl Cardiol 2004;11:171-85.PubMedCrossRef
20.
go back to reference Hachamovitch R, Berman DS, Shaw LJ, Kiat H, Cohen I, Cabico JA, et al. Incremental prognostic value of myocardial perfusion single photon emission computed tomography for the prediction of cardiac death: Differential stratification for risk of cardiac death and myocardial infarction. Circulation 1998;97:535-43.PubMed Hachamovitch R, Berman DS, Shaw LJ, Kiat H, Cohen I, Cabico JA, et al. Incremental prognostic value of myocardial perfusion single photon emission computed tomography for the prediction of cardiac death: Differential stratification for risk of cardiac death and myocardial infarction. Circulation 1998;97:535-43.PubMed
21.
go back to reference Berman DS, Kang X, Hayes SW, Friedman JD, Cohen I, Abidov A, et al. Adenosine myocardial perfusion single-photon emission computed tomography in women compared with men. Impact of diabetes mellitus on incremental prognostic value and effect on patient management. J Am Coll Cardiol 2003;41:1125-33.PubMedCrossRef Berman DS, Kang X, Hayes SW, Friedman JD, Cohen I, Abidov A, et al. Adenosine myocardial perfusion single-photon emission computed tomography in women compared with men. Impact of diabetes mellitus on incremental prognostic value and effect on patient management. J Am Coll Cardiol 2003;41:1125-33.PubMedCrossRef
22.
go back to reference Hachamovitch R, Hayes SW, Friedman JD, Cohen I, Berman DS. Stress myocardial perfusion single-photon emission computed tomography is clinically effective and cost effective in risk stratification of patients with a high likelihood of coronary artery disease (CAD) but no known cad. J Am Coll Cardiol 2004;43:200-8.PubMedCrossRef Hachamovitch R, Hayes SW, Friedman JD, Cohen I, Berman DS. Stress myocardial perfusion single-photon emission computed tomography is clinically effective and cost effective in risk stratification of patients with a high likelihood of coronary artery disease (CAD) but no known cad. J Am Coll Cardiol 2004;43:200-8.PubMedCrossRef
23.
go back to reference Boden WE, O’Rourke RA, Teo KK, Hartigan PM, Maron DJ, Kostuk WJ, et al. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med 2007;356:1503-16.PubMedCrossRef Boden WE, O’Rourke RA, Teo KK, Hartigan PM, Maron DJ, Kostuk WJ, et al. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med 2007;356:1503-16.PubMedCrossRef
24.
go back to reference Frye RL, August P, Brooks MM, Hardison RM, Kelsey SF, MacGregor JM, et al. A randomized trial of therapies for type 2 diabetes and coronary artery disease. N Engl J Med 2009;360:2503-15.PubMedCrossRef Frye RL, August P, Brooks MM, Hardison RM, Kelsey SF, MacGregor JM, et al. A randomized trial of therapies for type 2 diabetes and coronary artery disease. N Engl J Med 2009;360:2503-15.PubMedCrossRef
25.
go back to reference Iskandrian AS, Johnson J, Le TT, Wasserleben V, Cave V, Heo J. Comparison of the treadmill exercise score and single-photon emission computed tomographic thallium imaging in risk assessment. J Nucl Cardiol 1994;1:144-9.PubMedCrossRef Iskandrian AS, Johnson J, Le TT, Wasserleben V, Cave V, Heo J. Comparison of the treadmill exercise score and single-photon emission computed tomographic thallium imaging in risk assessment. J Nucl Cardiol 1994;1:144-9.PubMedCrossRef
26.
go back to reference Shaw LJ, Peterson ED, Shaw LK, Kesler KL, DeLong ER, Harrell FE Jr, et al. Use of a prognostic treadmill score in identifying diagnostic coronary disease subgroups. Circulation 1998;98:1622-30.PubMed Shaw LJ, Peterson ED, Shaw LK, Kesler KL, DeLong ER, Harrell FE Jr, et al. Use of a prognostic treadmill score in identifying diagnostic coronary disease subgroups. Circulation 1998;98:1622-30.PubMed
27.
go back to reference Mark DB, Hlatky MA, Harrell FE Jr, Lee KL, Califf RM, Pryor DB. Exercise treadmill score for predicting prognosis in coronary artery disease. Ann Intern Med 1987;106:793-800.PubMed Mark DB, Hlatky MA, Harrell FE Jr, Lee KL, Califf RM, Pryor DB. Exercise treadmill score for predicting prognosis in coronary artery disease. Ann Intern Med 1987;106:793-800.PubMed
28.
go back to reference Califf RM, Armstrong PW, Carver JR, D’Agostino RB, Strauss WE. 27th Bethesda conference: Matching the intensity of risk factor management with the hazard for coronary disease events. Task force 5. Stratification of patients into high, medium and low risk subgroups for purposes of risk factor management. J Am Coll Cardiol 1996;27:1007-19.PubMedCrossRef Califf RM, Armstrong PW, Carver JR, D’Agostino RB, Strauss WE. 27th Bethesda conference: Matching the intensity of risk factor management with the hazard for coronary disease events. Task force 5. Stratification of patients into high, medium and low risk subgroups for purposes of risk factor management. J Am Coll Cardiol 1996;27:1007-19.PubMedCrossRef
Metadata
Title
Nomograms for estimating coronary artery disease prognosis with gated stress myocardial perfusion SPECT
Authors
Leslee J. Shaw, PhD
James K. Min, MD
Rory Hachamovitch, MD, MS
Robert C. Hendel, MD
Salvador Borges-Neto, MD
Daniel S. Berman, MD
Publication date
01-02-2012
Publisher
Springer-Verlag
Published in
Journal of Nuclear Cardiology / Issue 1/2012
Print ISSN: 1071-3581
Electronic ISSN: 1532-6551
DOI
https://doi.org/10.1007/s12350-011-9468-7

Other articles of this Issue 1/2012

Journal of Nuclear Cardiology 1/2012 Go to the issue